European CHMP adopted positive opinion for HEPLISAV-Bᆴ hepatitis B adjuvanted vaccine
On Dec. 10, 2020, Dynavax Technologies announced that the European Medicines Agency (EMA) Committee for Medicinal Products for…
On Dec. 10, 2020, Dynavax Technologies announced that the European Medicines Agency (EMA) Committee for Medicinal Products for…
On Dec. 10, 2020, Pfizer and BioNTech announced that the FDA Vaccines and Related Biological Products Advisory Committee…
On Dec. 10, 2020, the U.S. Dept. of Veterans Affairs (VA) announced a preliminary plan for distributing COVID-19…
On Dec. 10, 2020, Roche announced a partnership with Moderna to utilise the Elecsys Anti-SARS-CoV-2 S antibody test…
On Dec. 10, 2020, ImmunityBio announced its COVID-19 vaccine candidate protected nasal and lung airways of non-human primates…
On Dec. 10, 2020, Moderna announced that the first adolescent participants had been dosed in the Phase 2/3…
On Dec. 9, 2020, LabCorp announced that the FDA had granted Emergency Use Authorization (EUA) for the Pixel…
On Dec. 9, 2020, Roche announced a partnership with Moderna to utilise the Elecsys Anti-SARS-CoV-2 S antibody test…
On Dec. 8, 2020, Pfizer announced that the FDA accepted for priority review a Biologics License Application (BLA)…
On Dec. 8, 2020, Moderna announced the Swiss Federal Government had increased its confirmed order commitment from 4.5…
On Dev. 8, 2020, University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials…
On Dec. 8, 2020, University of Alberta virologist Michael Houghton was awarded a share of the 2020 Nobel…
On Dec. 7, 2020, the Serum Institute of India (SII) announced that it had applied to Drugs Controller…
On Dec. 7, 2020, an universal influenza virus vaccine, which produces antibodies that target the part of the…
On Dec. 7, 2020, Matinas BioPharma announced that they planned to collaborate with the National Institute of Allergy…
On Dec. 7, 2020, Moderna announced that the Canadian Government had increased its confirmed order commitment by 20…
On Dec. 7, 2020, Chimerix announced the U.S. Food and Drug Administration (FDA) had accepted the filing of a…
On Dec. 7, 2020, Inovio Pharmaceuticals announced it had dosed its first subject in a Phase 2 clinical…
On Dec. 5, 2020, Dr. James Lim and Lakshana Sreenivasan discovered that certain immune signals may help medulloblastoma…
On Dec. 4, 2020, it was reported in JAMA that high-dose influenza (commonly known as flu) vaccines are…
On Dec. 4, 2020, researchers at the National Institutes of Health reported that they had made a surprising…
On Dec. 4, 2020, Los Angeles County launched a new COVID-19 home test collection program, which allowed certain…
On Dec. 4, 2020, Eli Lilly and UnitedHealth Group announced a partnership to conduct a pragmatic study of…
On Dec. 4, 2020, VBI Vaccines and Syneos Health announced a partnership for the commercialization of VBIメs 3-antigen…
On Dec. 4, 2020, Novo Nordisk announced that the FDA approved an updated label for Saxenda (liraglutide) injection…
On Dec. 4, 2020, the U.S. Food and Drug Administration (FDA) authorized the first diagnostic test for at home collection…
On Dec. 3, 2020, the U.S. Department of Defense in coordination with the Department of HHS, awarded a…
On Dec. 3, 2020, the Advisory Committee on Immunization Practices (ACIP) recommended, as interim guidance, that both 1)…
On Dec. 3, 2020, Meridian Bioscience announced that it had launched an Air-Dryable RT-qPCR Mix, driving innovation in…
On Dec. 3, 2020, a new study by researchers at the University of British Columbia and BC Children’s…